搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Aspergillus oryzae Probable beta-galactosidase B (lacB), partial CSB-YP648016DPA
CSB-EP648016DPA
CSB-BP648016DPA
CSB-MP648016DPA
CSB-EP648016DPA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aspergillus oryzae Probable Xaa-Pro aminopeptidase P (ampp), partial CSB-YP648017DPA
CSB-EP648017DPA
CSB-BP648017DPA
CSB-MP648017DPA
CSB-EP648017DPA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aspergillus oryzae Protein pbn1 (pbn1), partial CSB-YP648018DPA
CSB-EP648018DPA
CSB-BP648018DPA
CSB-MP648018DPA
CSB-EP648018DPA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aspergillus oryzae Hsp70 nucleotide exchange factor fes1 (fes1) CSB-YP648019DPA
CSB-EP648019DPA
CSB-BP648019DPA
CSB-MP648019DPA
CSB-EP648019DPA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aspergillus oryzae Cytosolic Fe-S cluster assembly factor cfd1 (cfd1) CSB-YP648020DPA
CSB-EP648020DPA
CSB-BP648020DPA
CSB-MP648020DPA
CSB-EP648020DPA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aspergillus oryzae Dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase (alg8), partial CSB-YP648021DPA
CSB-EP648021DPA
CSB-BP648021DPA
CSB-MP648021DPA
CSB-EP648021DPA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aspergillus oryzae FACT complex subunit spt16 (spt16), partial CSB-YP648022DPA
CSB-EP648022DPA
CSB-BP648022DPA
CSB-MP648022DPA
CSB-EP648022DPA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aspergillus oryzae Probable 1,4-beta-D-glucan cellobiohydrolase A (cbhA) CSB-YP648023DPA
CSB-EP648023DPA
CSB-BP648023DPA
CSB-MP648023DPA
CSB-EP648023DPA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aspergillus oryzae ATP-dependent rRNA helicase spb4 (spb4), partial CSB-YP648024DPA
CSB-EP648024DPA
CSB-BP648024DPA
CSB-MP648024DPA
CSB-EP648024DPA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aspergillus oryzae Actin cytoskeleton-regulatory complex protein end3 (end3) CSB-YP648025DPA
CSB-EP648025DPA
CSB-BP648025DPA
CSB-MP648025DPA
CSB-EP648025DPA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aspergillus oryzae Mitochondrial thiamine pyrophosphate carrier 1 (tpc1), partial CSB-YP648026DPA1
CSB-EP648026DPA1
CSB-BP648026DPA1
CSB-MP648026DPA1
CSB-EP648026DPA1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aspergillus oryzae Probable beta-glucosidase M (bglM), partial CSB-YP648027DPA
CSB-EP648027DPA
CSB-BP648027DPA
CSB-MP648027DPA
CSB-EP648027DPA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aspergillus oryzae Protein clp1 (clp1), partial CSB-YP648028DPA
CSB-EP648028DPA
CSB-BP648028DPA
CSB-MP648028DPA
CSB-EP648028DPA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aspergillus oryzae Mediator of RNA polymerase II transcription subunit 21 (srb7) CSB-YP648029DPA
CSB-EP648029DPA
CSB-BP648029DPA
CSB-MP648029DPA
CSB-EP648029DPA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aspergillus oryzae Probable E3 ubiquitin ligase complex SCF subunit sconB (sconB), partial CSB-YP648030DPA
CSB-EP648030DPA
CSB-BP648030DPA
CSB-MP648030DPA
CSB-EP648030DPA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aspergillus oryzae Ribosome biogenesis protein ytm1 (ytm1) CSB-YP648031DPA
CSB-EP648031DPA
CSB-BP648031DPA
CSB-MP648031DPA
CSB-EP648031DPA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aspergillus oryzae Mediator of RNA polymerase II transcription subunit 8 (med8) CSB-YP648032DPA
CSB-EP648032DPA
CSB-BP648032DPA
CSB-MP648032DPA
CSB-EP648032DPA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aspergillus oryzae NADPH--cytochrome P450 reductase (cprA), partial CSB-YP648033DPA
CSB-EP648033DPA
CSB-BP648033DPA
CSB-MP648033DPA
CSB-EP648033DPA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aspergillus oryzae Probable feruloyl esterase C (faeC) CSB-YP648034DPA
CSB-EP648034DPA
CSB-BP648034DPA
CSB-MP648034DPA
CSB-EP648034DPA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aspergillus oryzae Probable alpha-galactosidase B (aglB) CSB-YP648035DPA
CSB-EP648035DPA
CSB-BP648035DPA
CSB-MP648035DPA
CSB-EP648035DPA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時,你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗更有可能成功。但是如果你做了錯誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗總結(jié)出了幾個有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>